In this work, we report that MK-8876 may restore the sensitivity of chemotherapeutics that are P-gp substrates to cancer cells that overexpress P-gp, suggesting its potential in circumventing P-gp-mediated MDR in cancer. This evidence concerns the gene PGP and cancer.